img25199282_0.jpg

 

Exhibit 99.1

Interim Report for Q3 2026

IQM Quantum Computers Grows Order Backlog 52% Year to Date;

Reaffirms FY 2026 Guidance

 

IQM Quantum Computers Plc, Stock Exchange Release, Interim Report November 5, 2026 at 08:00 (EET)

ESPOO, FINLAND | November 5, 2026 | IQM Quantum Computers (Nasdaq: IQMX) (“IQM” or the “Company”), a global leader in superconducting quantum computers, today announced financial results for the third quarter and first nine months of 2026.

●
Booked EUR 42.2 million of new orders in Q3, led by LUMI-IQ Halocene, bringing year-to-date order intake to EUR 52.9 million
●
Order backlog of EUR 102.5 million at September 30, 2026, up 52% from the start of the year
●
Q3 revenue of EUR 8.9 million, up 51% year-over-year
●
Cash and cash equivalents of EUR 260.4 million at September 30, 2026
●
To date, 31 quantum computers sold globally, 17 delivered, 17 in production

 

“Q3 was a quarter of strong commercial momentum, with record new orders booked, our largest contract to date signed, and an expanded presence across four continents," said Dr. Jan Goetz, Co-Founder and Chief Executive Officer. “This quarter, a leading AI factory committed to a multi-year path toward logical qubits on IQM hardware, not just buying today's machine but investing in a roadmap they trust we will deliver. For years, the open question was whether quantum computers could work at all. Today, it is whether they can be built, delivered and operated at the pace the world needs them — and that is exactly what IQM was built for. With our first 150-qubit systems already at customer sites, we are focused on execution and building momentum toward our first error-correction demonstrators in 2027.”

Third Quarter 2026 Operational and Financial Highlights:

●
Extended IQM’s customer base to a fourth continent with its first quantum computer sale in South America, an IQM Spark for the Eldorado Research Institute in Campinas, Brazil’s largest technology cluster.
●
Announced the sale of second full-stack quantum computer to TOYO Corporation, an IQM Spark for TOYO's R&D center in Tokyo, supporting Japan’s national goal of ten million quantum users by 2030.

 


img25199282_0.jpg

 

●
Booked the first order for IQM Halocene, IQM’s error-correction platform, through a EUR 33 million contract with CSC’s LUMI AI Factory for a system on track to become Europe’s first superconducting quantum computer with logical qubits.
●
Selected for Phase 1 of the EuroHPC Joint Undertaking’s Quantum Grand Challenge, which aims to integrate European quantum hardware into supercomputing centers across Europe.
●
Started integrating Quantistry’s assets, adding an AI-powered chemistry and materials simulation platform and an experienced team that lets chemists and engineers, not just quantum specialists, run their own use cases.
●
Gross margin of 47% in Q3, compared to 46% in the second quarter.
●
Cash and cash equivalents of EUR 260.4 million as of September 30, 2026, compared to EUR 309.4 million following the July listing, reflecting operating cash outflow, one-time listing costs and capital investment in fab and assembly capacity.

 


img25199282_0.jpg

 

Key Figures

Unaudited interim condensed consolidated statement of loss

 

For the three months ended September 30,

 

For the nine months ended September 30,

 

in EUR thousand

2026

 

2025

 

2026

 

2025

 

 

 

 

 

 

 

 

 

 

Revenue from contracts with customers

 

8,857

 

 

5,877

 

 

17,727

 

 

11,911

 

Cost of revenue

 

(4,696

)

 

(3,541

)

 

(9,961

)

 

(7,168

)

Gross profit

 

4,161

 

 

2,336

 

 

7,766

 

 

4,743

 

 

 

 

 

 

 

 

 

 

Selling expenses

 

(4,349

)

 

(1,418

)

 

(11,398

)

 

(3,784

)

General and administrative expenses

 

(27,035

)

 

(2,748

)

 

(53,236

)

 

(9,660

)

Research and development expenses

 

(20,354

)

 

(13,737

)

 

(54,401

)

 

(39,387

)

Impairment losses (including reversals of impairment losses) on financial assets

 

127

 

 

-

 

 

147

 

 

(4

)

Other operating income

 

5,137

 

 

1,512

 

 

8,279

 

 

2,450

 

Other operating expenses

 

(1,870

)

 

(64

)

 

(1,876

)

 

(112

)

Share listing expense

 

(127,055

)

 

-

 

 

(127,055

)

 

-

 

Operating loss

 

(171,236

)

 

(14,119

)

 

(231,773

)

 

(45,754

)

 

 

 

 

 

 

 

 

 

Finance income

 

23,359

 

 

1,795

 

 

28,426

 

 

2,764

 

Finance costs

 

(4,530

)

 

(288

)

 

(23,930

)

 

(4,138

)

Loss before income tax

 

(152,407

)

 

(12,612

)

 

(227,278

)

 

(47,128

)

 

 

 

 

 

 

 

 

 

Income tax

 

(223

)

 

-

 

 

(249

)

 

(59

)

Loss for the period

 

(152,630

)

 

(12,612

)

 

(227,527

)

 

(47,187

)

 

 

 

 

 

 

 

 

 

Attributable to:

 

 

 

 

 

 

 

 

Equity holders of the parent

 

(152,630

)

 

(12,612

)

 

(227,527

)

 

(47,187

)

 

 

 

 

 

 

 

 

 

Loss per share (in EUR) attributable to the ordinary equity holders of the company:

 

 

 

 

 

 

 

 

Basic loss per share

 

(0.81

)

 

(0.41

)

 

(2.72

)

 

(1.54

)

Diluted loss per share

 

(0.81

)

 

(0.41

)

 

(2.72

)

 

(1.54

)

 

“Revenue for the first nine months of 2026 grew 49% year-over-year, entirely from commercial contracts with no public funding or grants in that figure,” added Jan Kürschner, Chief Financial Officer. “We ended the quarter with EUR 260.4 million in cash, providing a strong foundation for our business as we continue to invest with discipline in customer deliveries, our technology roadmap, and expanding our fab capacity.”

2026 Financial Outlook

We are reiterating our full-year 2026 guidance:

●
Full-year order intake of 65 million to 75 million Euros.
●
Full-year revenue of 42 million to 47 million Euros.

IQM recognizes revenue from standardized systems at the point when the customer accepts the system, not when it ships or is installed. Acceptance depends partly on factors on the customer side, such as site readiness, cooling and power infrastructure, and public-sector procurement sign-off.

 


img25199282_0.jpg

 

Larger, customized projects are recognized over time as milestones are reached. If an acceptance moves by a few weeks across a quarter-end, the revenue moves with it; the contract value, the backlog and the cash profile do not change.

Detailed Discussion

This release contains a summary of IQM Quantum Computers’ financial results for the third quarter and first nine months of 2026. The summary focuses on group-level financial information and the Company’s outlook. Detailed financial information and notes are available in the interim report accompanying this release and on the Company's website at https://investors.iqm.tech/. We encourage investors to review the tables and notes in the full report as well.

Conference Call Details

IQM will host a conference call today, November 5, 2026, at 3:00 PM EET / 2:00 PM CET / 8:00 AM EST to discuss its third quarter 2026 financial results. A live audio webcast will be available in the News & Events section of the Company’s Investor Relations website at https://investors.iqm.tech/. A replay will be available at the same location for one year following the call.

About IQM Quantum Computers

IQM Quantum Computers (Nasdaq: IQMX) is a global leader in integrated quantum computing, delivering full-stack superconducting quantum computers to enterprises, research institutions, universities, high-performance computing centers and national laboratories worldwide. With more on-premises systems sold than any other manufacturer, IQM gives customers direct ownership and control of quantum computers that integrate with their supercomputing and AI infrastructure, with cloud access also available through IQM Resonance. From processors made in its own fabrication facility to an open software stack, IQM is advancing toward fault-tolerant quantum computing. Founded in 2018 and headquartered in Espoo, Finland, with major operations in Munich, Germany, IQM employs more than 450 people across Europe, Asia and North America. IQM is the first publicly listed European quantum company on the Nasdaq Stock Market.

Contacts

IQM Media contact

press@iqm.tech

IQM Investor contact

investors@iqm.tech

Key Operating Metrics

In addition to the measures presented in our consolidated financial statements, we use order backlog and order intake as indicators of future revenues from existing signed orders. This approach provides management with a transparent bridge from confirmed orders to revenue, linking sales

 


img25199282_0.jpg

 

performance with revenue realization, while remaining consistent with the external definition of backlog as confirmed, not yet recognized orders. We believe these metrics provide useful information for the market to understand and evaluate our results of operations in the same manner as our management team. Order backlog represents the value of binding customer orders that have been confirmed but not yet recognized as revenue at a point in time. We calculate order backlog as the point in time balance of order Intake less recognized revenue. Order intake represents the total monetary value of binding customer orders signed during the period, excluding pipeline or expected orders, and reflects new business secured and future revenue generation. These metrics are presented for supplemental informational purposes only, should not be considered substitutes for financial information presented in accordance with IFRS Accounting Standards, and may differ from similarly titled metrics or measures presented by other companies. In this release, we have provided our order backlog as of September 30, 2026.

Cautionary Language and Forward-Looking Statements

Certain statements herein that are not historical facts are forward-looking statements. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” “intends,” “outlook,” “may,” “will,” and other similar terms and phrases. Such forward-looking statements include, but are not limited to, statements regarding IQM’s strategies, future or anticipated market or competitive position, business plans and future performance, including IQM’s cash runway and outlook for the full-year 2026. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: A) expectations, plans, benefits or outlook related to our strategies, projects, programs, product launches, growth management, licenses, intellectual property, sustainability and other ESG targets, operational key performance indicators and decisions on market exits or expansions; B) expectations, plans or benefits related to future performance of our businesses (including the expected impact, timing and duration of potential global pandemics, geopolitical conflicts and the general or regional macroeconomic conditions on our businesses, our supply chain, the timing of market changes or turning points in demand and our customers’ businesses); C) expectations and targets regarding financial performance and results of operations, including market share, prices, net sales, order backlog, order intake, income, margins, cash flows, cost savings, the timing of receivables, operating expenses, provisions, impairments, tariffs, taxes, currency exchange rates, hedging, investment funds, inflation, product cost reductions, competitiveness, value creation, and revenue generation in any specific region; D) our ability to execute, expectations, plans or benefits related to transactions, investments and changes in organizational structure and operating model, including the expansion of our manufacturing and production capacity; E) expectations related to the commercialization and market acceptance of quantum technology and the timing and progress of product development; and F) other risks and uncertainties described in IQM’s public filings and regulatory releases from time to time. These statements are based on management's best assumptions and beliefs in light of the information currently available to them. IQM anticipates that subsequent events and developments may cause its views to change. IQM specifically disclaims any obligation to update the forward-looking statements in this stock exchange release except as

 


img25199282_0.jpg

 

required by law. These forward-looking statements should not be relied upon as representing IQM’s views as of any date subsequent to the date hereof.

 


img25199282_0.jpg

 

Interim condensed consolidated statement of financial position

 

Unaudited

 

 

 

in EUR thousand

September 30, 2026

 

December 31, 2025

 

Assets

 

 

 

 

Non-current assets

 

 

 

 

Intangible assets

 

2,645

 

 

920

 

Property, plant and equipment

 

63,266

 

 

57,931

 

Right-of-use assets

 

10,137

 

 

10,949

 

Financial assets

 

1,300

 

 

910

 

Total non-current assets

 

77,348

 

 

70,710

 

Current assets

 

 

 

 

Inventories

 

34,287

 

 

13,491

 

Contract assets

 

7,130

 

 

7,286

 

Trade receivables

 

12,059

 

 

15,489

 

Other financial assets

 

1,337

 

 

876

 

Other current assets

 

19,671

 

 

11,216

 

Cash and cash equivalents

 

260,418

 

 

146,544

 

Total current assets

 

334,902

 

 

194,903

 

 

 

 

 

 

Total assets

 

412,250

 

 

265,613

 

 

 

 

 

 

in EUR thousand

September 30, 2026

 

December 31, 2025

 

Equity and liabilities

 

 

 

 

Equity

 

 

 

 

Share capital

 

80

 

 

3

 

Capital reserves

 

789,194

 

 

438,157

 

Retained earnings

 

(459,770

)

 

(232,243

)

Other reserves

 

222

 

 

(16

)

Total equity

 

329,725

 

 

205,900

 

Non-current liabilities

 

 

 

 

Financial liabilities

 

2,160

 

 

9,222

 

Lease liabilities

 

11,285

 

 

12,185

 

Employee benefits

 

12

 

 

14

 

Total non-current liabilities

 

13,457

 

 

21,420

 

Current liabilities

 

 

 

 

Trade payables

 

16,145

 

 

8,855

 

Lease liabilities

 

2,385

 

 

2,475

 

Financial liabilities

 

22,871

 

 

8,525

 

Contract liabilities

 

4,680

 

 

7,406

 

Employee benefits

 

10,854

 

 

5,908

 

Other current liabilities

 

12,133

 

 

5,124

 

Total current liabilities

 

69,068

 

 

38,292

 

Total liabilities

 

82,525

 

 

59,713

 

 

 

 

 

 

Total equity and liabilities

 

412,250

 

 

265,613

 

 

 


img25199282_0.jpg

 

Unaudited interim condensed consolidated statement of cashflows

 

 

For the nine months ended September 30,

 

in EUR thousand

2026

 

2025

 

 

 

 

 

 

 

Loss for the period

 

(227,527

)

 

(47,187

)

 

 

 

 

 

 

 

Adjustments for:

 

 

 

 

 

 Depreciation expense, amortization and
 impairment

 

9,587

 

 

9,378

 

 

 Provisions

 

-

 

 

(40

)

 

 Other adjustments for non-cash items

 

(348

)

 

(69

)

 

 Share listing expense

 

127,055

 

 

-

 

 

 Share-based payments

 

15,236

 

 

3,460

 

 

 Finance income/cost

 

(4,496

)

 

1,237

 

 

 Income tax expense

 

249

 

 

59

 

 

Changes in:

 

 

 

 

 

 Inventories

 

(20,797

)

 

(1,969

)

 

 Contract assets

 

157

 

 

(3,136

)

 

 Trade receivables

 

3,382

 

 

(210

)

 

 Other financial assets

 

(1,781

)

 

-

 

 

 Other assets

 

(15,254

)

 

(36,133

)

 

 Trade payables

 

7,290

 

 

1,627

 

 

 Contract liabilities

 

(2,714

)

 

(1,444

)

 

 Employee benefits

 

4,725

 

 

115

 

 

 Other liabilities

 

7,025

 

 

(245

)

 

 Income taxes paid

 

(249

)

 

(2

)

Cashflow from operating activities

 

(98,458

)

 

(74,559

)

 

 

 

 

 

 

 

Payments for acquisition of business, net of cash acquired

 

(1,900

)

 

-

 

 

Proceeds from disposals of property, plant, and equipment

 

-

 

 

21

 

 

Purchases of property, plant and equipment

 

(8,173

)

 

(3,630

)

 

Refund from purchase of property, plant and equipment

 

1,000

 

 

-

 

 

Payments for acquisition of subsidiary - net of cash

 

(7

)

 

-

 

 

Deposits and guarantees

 

(391

)

 

176

 

 

Interest received

 

2,443

 

 

1,152

 

Cashflow from investing activities

 

(7,027

)

 

(2,281

)

 

 

 

 

 

 

 

Proceeds from equity contributions

 

208,463

 

 

270,299

 

 

Transaction costs related to equity contributions

 

(5,496

)

 

(617

)

 

Share buybacks

 

-

 

 

(22,421

)

 

Exercise of warrants

 

20,468

 

 

-

 

 

Proceeds from loans and borrowings

 

5,000

 

 

7

 

 

Transaction costs related to loans

 

(775

)

 

-

 

 

Repayments of loans and borrowings

 

(5,250

)

 

(5,961

)

 

Repayments of lease liabilities

 

(2,000

)

 

(2,837

)

 

Lease incentives received

 

-

 

 

824

 

 

Interest paid

 

(1,836

)

 

(788

)

Cashflow from financing activities

 

218,575

 

 

238,505

 

 

 

 

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

113,090

 

 

161,666

 

 

Cash and cash equivalents at the beginning of year

 

146,544

 

 

17,247

 

+

Effects of exchange rate changes on cash and cash equivalents

 

784

 

 

(43

)

Cash and cash equivalents at the end of period

 

260,418

 

 

178,870

 

Attachments

●
Interim Report